Cointime

Aspect Biosystems

company

About

Biotech company developing bioprinted tissue therapeutics to transform how we treat disease.

  • 51 - 100

Highlights

Total Funding Amount
$2.70M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Grant
Last Funding Money Raised
$2.70M
Industries
Biotechnology,Life Science
Founded date
Nov 19, 2013
Number Of Employee
51 - 100
Operating Status
Active

Aspect Biosystems is a biotechnology company developing bioprinted tissue therapeutics to transform how we treat disease. By combining its proprietary microfluidic 3D bioprinting technology, therapeutic cells, and materials science, Aspect is creating a pipeline of allogeneic cell-based tissue therapeutics to replace or repair damaged organ functions. The company is also partnering with leading researchers and industry innovators worldwide to tackle the biggest challenges in regenerative medicine.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$2.70M
Aspect Biosystems has raised a total of $2.70M in funding over 2 rounds. Their latest funding was raised on Nov 15, 2018 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 15, 2018 Grant $2.70M 1 Western Innovation (WINN) Initiative — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Aspect Biosystems is funded by 1 investors. Western Innovation (WINN) Initiative are the most recent investors.
Investor Name Lead Investor Funding Round
Western Innovation (WINN) Initiative Yes Grant
Cointime
Содержание
компания